Back

Economic outcomes of the CAT-CAD randomised trial assessing coronary artery computed tomography as the first-choice anatomic test for individuals with suspected significant coronary artery disease

29 August 2017 (15:35 - 16:25)
Organised by:
Congress Presentation Part of: Diagnostic modalities in stable CAD Angina pectoris stable ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Piotr Nikodem Rudzinski

National Institute of Cardiology, Warsaw (Poland)

6 More presentations in this session

Presentation thumbnail
Diagnostic accuracy of hyperemic instantaneous wave-free ratio for obstructive coronary artery disease based on lesion location
Doctor H. Takahashi (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Prediction of standard of care guided coronary revascularisation by FFRct is preserved across a broad range of coronary calcification.
Doctor D. Akkan (Slagelse, DK)
Abstract Slides
Presentation thumbnail
The new biomarkers in coronary artery disease - the diagnostic and prognostic value of insulin like growth factor binding protein 7 (IGFBP 7) and galectin 3 (Gal 3).
Doctor A. Lisowska (Bialystok, PL)
Abstract
Presentation thumbnail
COMBINE OCT and FFR assessment of non culprit lesions to better predict adverse event outcomes in diabetes mellitus patients. Rationale, design and initial OCT results
Doctor E. Kedhi (Brussels, BE)
Abstract Slides
Presentation thumbnail
FFRct to predict coronary revascularisation - a real-world experience
Doctor D. Akkan (Slagelse, DK)
Abstract Slides

Access the full session

Session thumbnail
Diagnostic modalities in stable CAD

The Event

Event poster

ESC Congress 2017

29 August 2017 15:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources